The team of the GMP unit CellGENTherapies will be present at the mRNA-Based Therapeutics Summit in Frankfurt Germany on 28th-30th of Jan 2025 – Europe’s Largest Industry-Led & Dedicated Gathering for mRNA Leaders

4th mRNA-Based Therapeutics Summit 2025 | Home

With 40+ World-Class Speakers and assembling 200+ mRNA enthusiasts from across Europe, Asia and the globe, the 4th mRNA-Based Therapeutics Summit Europe is a key forum dedicated to showcasing cutting-edge R&D innovations, providing unrivaled knowledge-sharing, whilst diving deep into end-to-end development strategy to revolutionise the next wave of mRNA medicines towards clinical reality.

Feel free to pass by our booth to discuss the mRNA capabilities of our GMP unit.

• Tim De Smet, Business Developer Advanced Cell and Tissue Therapies UZGent – UGent
• Joline Ingels, Head of Production GMP unit CellGENTherapies UZGent
• Katrien Vanhonacker, Business Development GMP unit CellGENTherapies UZGent

POST EVENT UPDATE

Very successful days for CellGENTherapies, the GMP unit of University Hospital Ghent, at the mRNA-Based Therapeutics Summit in Frankfurt.

We had great discussions with several players in the mRNA therapeutics field on small-scale production of mRNA vaccines and mRNA-LNPs for early clinical trials of both off-the-shelf as well as of personalized medicines in accordance with Good Manufacturing Practices (GMP). Definitely a role of CellGENTherapies that continues resonating with the industry.